BioSpace News Archive

A study comparing short-term outcomes of minimally invasive (MI) lumbar decompression surgery to MI lumbar spine fusion surgery found no statistically significant difference in the amount of time patients needed to return to work.

Lifelong biotech leader Samuel Tong was a former executive in Asia of several large multinationals, including QIAGEN, Becton Dickinson and Abbott

Poor insulin handling associated with negative cardiovascular outcomes Preclinical data also presented showing MSDC-0602K restored pancreatic islet insulin content when used alone or in combination with liraglutide

MedRhythms announced that it has received Breakthrough Device designation from the U.S. Food and Drug Administration for its patented digital therapeutic to treat chronic stroke walking deficits.

Loki Therapeutics, an immuno-oncology company developing next-generation cancer therapeutics that leverage childhood vaccination recall antigens, today announced the formation of its Scientific Advisory Board (SAB), and the appointment of several prominent members, including Eileen O’Reilly , MD, of Memorial Sloan Kettering C

4Front Ventures Corp. (CSE: FFNT) (OTCQX: FFNTF) (“4Front” or the “Company”) today announced its audited financial results for the fourth quarter and Fiscal Year 2019 and preliminary results for the First Quarter of 2020.

Codiak to Present New Preclinical Data on exoASO™-STAT6 and exoASO-C/EBPβ at the AACR 2020 Virtual Annual Meeting

Foundation Medicine, Inc., today announced the appointment of Dr. Geoffrey R. Oxnard as vice president, global medical lead for the Company’s liquid biopsy portfolio, effective immediately.

Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today reported the success of its initiative to conduct safe patient screenings remotely using telehealth technologies.

Building on Merck for Mothers’ Efforts, Initiative Bolsters Support for Locally Created Solutions to Improve Maternal Health and Narrow Disparities During the COVID-19 Pandemic and Beyond KENILWORTH, N.J.--( BUSINESS WIRE )-- Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today it was expanding its Safer Childbirth Cities initiative, a multi-year effort to improve U.S. maternal health outcomes. Safer Childbirth Citie